Skip to main content
Top
Literature
1.
go back to reference Mollaeian A, Haas C (2020) A tale of autoimmunity: thymoma, thymectomy, and systemic lupus erythematosus. Clin Rheumatol 39(7):2227–2234CrossRef Mollaeian A, Haas C (2020) A tale of autoimmunity: thymoma, thymectomy, and systemic lupus erythematosus. Clin Rheumatol 39(7):2227–2234CrossRef
2.
go back to reference Tarr PE et al (2001) Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine (Baltimore) 80(2):123–133CrossRef Tarr PE et al (2001) Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine (Baltimore) 80(2):123–133CrossRef
3.
go back to reference Furukawa R, Yanagiya M, Matsumoto J, Hashimoto H, Horiuchi H, Usui K (2018) Good's syndrome with clinical manifestation after thymectomy: a case report. Respir Med Case Rep 24:89–91PubMedPubMedCentral Furukawa R, Yanagiya M, Matsumoto J, Hashimoto H, Horiuchi H, Usui K (2018) Good's syndrome with clinical manifestation after thymectomy: a case report. Respir Med Case Rep 24:89–91PubMedPubMedCentral
4.
go back to reference Kelesidis T, Yang O (2010) Good's syndrome remains a mystery after 55 years: a systematic review of the scientific evidence. Clin Immunol 135(3):347–363CrossRef Kelesidis T, Yang O (2010) Good's syndrome remains a mystery after 55 years: a systematic review of the scientific evidence. Clin Immunol 135(3):347–363CrossRef
5.
go back to reference Kelleher P, Misbah SA (2003) What is Good's syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol 56(1):12–16CrossRef Kelleher P, Misbah SA (2003) What is Good's syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol 56(1):12–16CrossRef
Metadata
Title
Response to: Caution the masqueraders of Good’s syndrome on the thymoma with systemic lupus erythematosus
Authors
Arash Mollaeian
Christopher J. Haas
Publication date
01-02-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 2/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05575-6

Other articles of this Issue 2/2021

Clinical Rheumatology 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.